Avadel Pharmaceuticals (AVDL) Interest & Investment Income (2016 - 2020)
Historic Interest & Investment Income for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to $74000.0.
- Avadel Pharmaceuticals' Interest & Investment Income rose 10500.34% to $74000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.9 million, marking a year-over-year decrease of 28082.32%. This contributed to the annual value of -$832000.0 for FY2020, which is 17782.97% down from last year.
- According to the latest figures from Q4 2020, Avadel Pharmaceuticals' Interest & Investment Income is $74000.0, which was up 10500.34% from $213000.0 recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' Interest & Investment Income registered a high of $977000.0 during Q3 2017, and its lowest value of -$1.5 million during Q4 2019.
- Moreover, its 5-year median value for Interest & Investment Income was $390000.0 (2016), whereas its average is $292210.5.
- Examining YoY changes over the last 5 years, Avadel Pharmaceuticals' Interest & Investment Income showed a top increase of 141296.3% in 2019 and a maximum decrease of 27633.59% in 2019.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Interest & Investment Income stood at $555000.0 in 2016, then crashed by 48.11% to $288000.0 in 2017, then plummeted by 236.46% to -$393000.0 in 2018, then tumbled by 276.34% to -$1.5 million in 2019, then soared by 105.0% to $74000.0 in 2020.
- Its last three reported values are $74000.0 in Q4 2020, $213000.0 for Q3 2020, and -$741000.0 during Q2 2020.